- Lonza is investing in the expansion of its bioconjugation facility in Visp, Switzerland, adding two 1,200L multipurpose manufacturing suites.
- The expansion, which will create 200 new jobs, is expected to be operational by 2028 and will double Lonza’s bioconjugation capacity for ADC and other bioconjugates.
Lonza, a global contract development and manufacturing organization (CDMO), is expanding its bioconjugation facility in Visp, Switzerland, to address the growing demand for antibody-drug conjugates (ADCs) and other bioconjugates. The company will invest in two new multipurpose 1,200L manufacturing suites, which will add 2,000m² of production space to the existing site.
The new facilities, expected to be operational by 2028, will support both launch and commercial supply, enabling Lonza to offer integrated manufacturing solutions for the bioconjugate market. The expansion is anticipated to create approximately 200 new jobs, further enhancing the company’s ability to meet market needs.
Christian Morello, Vice President and Head of Bioconjugates at Lonza, stated, “This investment in our multipurpose commercial bioconjugation capacity addresses the growing market demand, enables us to support the growth of our customers, and offers a flexible and integrated service for manufacturing bioconjugates.”
The bioconjugation suites will be designed to handle complex and variable manufacturing processes, ensuring flexibility for multiple customers. In addition, the expansion includes drug product filling capabilities and supports Lonza’s broader offering, which spans early-phase clinical development to large-scale commercial supply.
Lonza has a long history in bioconjugate manufacturing, having produced over 1,000 cGMP batches for more than 70 programs since 2006. The company’s investment in sustainability is also a key focus, with the new suites being designed to reduce energy consumption and carbon emissions, alongside improved waste management technology.
Read about ADC Antibody Drug Conjugates CDMO Market 2024 Here.
Overview of outsourcing trends 
